Nutrien (NTR) Financials

$56.24 +0.04 (+0.07%)

As of 02:50 PM Eastern

Annual Income Statements for Nutrien

This table shows Nutrien's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	327	7,160	1,232	459	6,358	7,687	2,641	1,797
Consolidated Net Income / (Loss)	327	3,573	1,232	459	3,179	7,687	1,282	700
Net Income / (Loss) Continuing Operations	154	3,587	1,232	459	3,179	7,687	1,359	1,097
Total Pre-Tax Income	-29	3,494	1,308	382	4,168	10,246	1,952	1,136
Total Operating Income	209	4,032	1,862	902	4,781	10,809	2,745	1,856
Total Gross Profit	694	5,392	5,502	5,239	9,409	15,424	8,474	7,530
Total Revenue	4,547	18,772	20,084	20,908	27,712	37,884	29,056	25,972
Operating Revenue	4,547	18,772	20,084	20,908	27,712	37,884	29,056	25,972
Total Cost of Revenue	3,853	13,380	14,582	15,669	18,303	22,460	20,582	18,442
Operating Cost of Revenue	3,853	13,380	14,582	15,669	18,303	22,460	20,582	18,442
Total Operating Expenses	485	1,360	3,400	4,337	4,628	4,615	5,652	5,277
Selling, General & Admin Expense	214	2,760	3,013	3,311	3,817	3,979	4,023	4,079
Other Operating Expenses / (Income)	271	409	507	202	778	1,416	855	668
Impairment Charge	0.00	-1,809	-120	824	33	-780	774	530
Total Other Income / (Expense), net	-238	-538	-554	-520	-613	-563	-793	-720
Other Income / (Expense), net	-238	-538	-554	-520	-613	-563	-793	-720
Income Tax Expense	-183	-93	316	-77	989	2,559	670	436
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	0.00	-26	-	-24	-26
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	-	-	-	-3,153	-	-1,258	-674
Basic Earnings per Share	$0.39	$5.72	$1.70	$0.81	$5.53	-	$2.53	$1.36
Weighted Average Basic Shares Outstanding	840.08M	624.90M	582.27M	569.66M	569.66M	-	496.38M	494.20M
Diluted Earnings per Share	$0.39	$5.72	$1.70	$0.81	$5.52	-	$2.53	$1.36
Weighted Average Diluted Shares Outstanding	840.32M	624.90M	583.10M	569.69M	571.29M	-	496.99M	494.37M

No quarterly income statements for Nutrien are available.

This table details how cash moves in and out of Nutrien's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	84	3,600	-1,643	243	-2,184	9,968	1,786	2,117
Net Cash From Operating Activities	-1,225	2,052	3,665	3,323	3,886	10,000	2,861	2,806
Net Cash From Continuing Operating Activities	1,081	5,474	3,665	3,323	3,814	10,000	2,861	2,806
Net Income / (Loss) Continuing Operations	327	3,573	992	459	3,179	7,687	1,282	700
Consolidated Net Income / (Loss)	-327	3,573	992	459	3,179	7,687	1,282	700
Depreciation Expense	-	1,592	1,799	1,989	1,951	2,012	2,169	2,339
Non-Cash Adjustments To Reconcile Net Income	-898	1,925	224	893	373	-154	-532	-311
Changes in Operating Assets and Liabilities, net	-	-1,616	650	-18	-1,689	455	-58	78
Net Cash From Investing Activities	-652	3,887	-2,798	-1,204	-1,807	0.00	31	112
Net Cash From Continuing Investing Activities	-652	1,867	-2,798	-1,744	-2,964	0.00	31	112
Purchase of Investments	0.00	-	-198	-	-	-	31	112
Net Cash From Financing Activities	-489	-3,705	-2,479	-1,339	-3,003	-32	-1,106	-801
Net Cash From Continuing Financing Activities	-489	-3,705	-2,479	-1,339	-3,003	-32	-1,106	-801
Repayment of Debt	-159	-960	-794	-1,690	-1,195	-561	-648	-659
Issuance of Debt	-1.00	0.00	1,481	1,541	86	529	-458	-142
Cash Interest Paid	-	507	505	498	491	482	729	740

No quarterly cash flow statements for Nutrien are available.

This table presents Nutrien's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	16,998	45,502	46,799	47,192	49,954	54,586	52,749	51,840
Total Current Assets	3,323	11,662	10,665	11,470	13,846	16,342	14,170	13,792
Cash & Equivalents	116	2,314	671	1,454	499	901	941	853
Accounts Receivable	489	3,342	3,542	3,626	5,366	6,194	5,398	5,390
Inventories, net	2,646	4,917	4,975	4,930	6,328	7,632	6,336	6,148
Prepaid Expenses	72	1,089	1,477	1,460	1,653	1,615	1,495	1,401
Plant, Property, & Equipment, net	0.00	18,796	20,335	19,660	0.00	0.00	0.00	0.00
Total Noncurrent Assets	13,675	15,044	15,799	16,062	36,108	16,477	15,382	14,746
Goodwill	97	11,431	11,986	12,198	12,220	12,368	12,114	12,043
Intangible Assets	69	2,210	2,428	2,388	2,340	2,297	2,217	1,819
Other Noncurrent Operating Assets	13,509	1,403	564	914	20,845	1,812	1,051	884
Total Liabilities & Shareholders' Equity	16,998	45,502	46,799	47,192	49,954	54,586	52,749	51,840
Total Liabilities	8,695	21,077	23,930	24,789	26,255	28,723	27,548	27,398
Total Current Liabilities	1,602	8,335	9,129	8,480	12,443	14,280	12,121	12,045
Short-Term Debt	730	1,624	1,478	173	2,105	2,684	2,327	2,571
Accrued Expenses	836	-	-	-	10,052	11,291	9,467	9,118
Other Current Liabilities	-	8.00	214	249	286	305	327	356
Total Noncurrent Liabilities	7,093	12,742	14,801	16,309	13,812	14,443	15,427	15,353
Long-Term Debt	3,711	7,755	8,553	10,047	7,521	8,275	9,113	9,045
Capital Lease Obligations	-	12	859	891	-	899	999	999
Asset Retirement Reserve & Litigation Obligation	651	1,673	1,650	1,597	1,566	1,403	1,489	1,543
Noncurrent Deferred & Payable Income Tax Liabilities	2,205	2,907	3,145	3,149	3,165	3,547	3,574	3,539
Noncurrent Employee Benefit Liabilities	440	395	433	454	419	319	252	227
Total Equity & Noncontrolling Interests	8,303	24,425	22,869	22,403	23,699	25,863	25,201	24,442
Total Preferred & Common Equity	8,303	24,425	22,869	22,403	23,699	25,818	25,156	24,407
Total Common Equity	8,303	24,425	22,869	22,365	23,652	25,818	25,156	24,407
Common Stock	1,806	16,971	16,019	15,878	15,457	14,281	13,921	13,816
Retained Earnings	6,242	7,745	7,101	6,606	8,192	11,928	11,531	11,106
Accumulated Other Comprehensive Income / (Loss)	25	-291	-251	-119	-146	-391	-296	-515
Noncontrolling Interest	-	-	-	-	-	45	45	35

No quarterly balance sheets for Nutrien are available.

This table displays calculated financial ratios and metrics derived from Nutrien's official financial filings.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	312.84%	6.99%	4.10%	32.54%	36.71%	-23.30%	-10.61%
EBITDA Growth	0.00%	17,637.93%	-38.91%	-23.69%	158.08%	100.33%	-66.38%	-15.68%
EBIT Growth	0.00%	12,148.28%	-62.56%	-70.80%	991.10%	145.83%	-80.95%	-41.80%
NOPAT Growth	0.00%	2,729.34%	-65.88%	-23.25%	236.45%	122.39%	-77.77%	-36.56%
Net Income Growth	0.00%	992.66%	-65.52%	-62.74%	592.59%	141.81%	-83.32%	-45.40%
EPS Growth	0.00%	1,366.67%	-70.28%	-52.35%	581.48%	0.00%	0.00%	-46.25%
Operating Cash Flow Growth	0.00%	267.51%	78.61%	-9.33%	16.94%	157.33%	-71.39%	-1.92%
Free Cash Flow Firm Growth	0.00%	0.00%	97.03%	555.42%	63.08%	733.33%	-86.68%	-48.01%
Invested Capital Growth	0.00%	149.46%	5.97%	-2.38%	1.98%	-53.14%	-10.30%	-4.44%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	15.26%	28.72%	27.39%	25.06%	33.95%	40.71%	29.16%	28.99%
EBITDA Margin	-0.64%	27.09%	15.47%	11.34%	22.08%	32.36%	14.18%	13.38%
Operating Margin	4.60%	21.48%	9.27%	4.31%	17.25%	28.53%	9.45%	7.15%
EBIT Margin	-0.64%	18.61%	6.51%	1.83%	15.04%	27.05%	6.72%	4.37%
Profit (Net Income) Margin	7.19%	19.03%	6.13%	2.20%	11.47%	20.29%	4.41%	2.70%
Tax Burden Percent	-1,127.59%	102.26%	94.19%	120.16%	76.27%	75.02%	65.68%	61.62%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	0.00%	-2.66%	24.16%	-20.16%	23.73%	24.98%	34.32%	38.38%
Return on Invested Capital (ROIC)	1.16%	18.76%	4.50%	3.40%	11.46%	34.38%	12.63%	8.66%
ROIC Less NNEP Spread (ROIC-NNEP)	5.34%	8.83%	2.17%	-3.36%	6.13%	69.78%	17.25%	12.48%
Return on Net Nonoperating Assets (RNNOA)	2.78%	3.07%	0.71%	-1.37%	2.33%	-3.36%	-7.61%	-5.84%
Return on Equity (ROE)	3.94%	21.83%	5.21%	2.03%	13.79%	31.02%	5.02%	2.82%
Cash Return on Invested Capital (CROIC)	0.00%	-66.78%	-1.30%	5.81%	9.50%	106.75%	23.49%	13.21%
Operating Return on Assets (OROA)	-0.17%	11.18%	2.83%	0.81%	8.58%	19.60%	3.64%	2.17%
Return on Assets (ROA)	1.92%	11.43%	2.67%	0.98%	6.54%	14.71%	2.39%	1.34%
Return on Common Equity (ROCE)	3.94%	21.83%	5.21%	2.03%	13.77%	30.96%	5.01%	2.82%
Return on Equity Simple (ROE_SIMPLE)	3.94%	14.63%	5.39%	2.05%	13.41%	29.77%	5.10%	2.87%
Net Operating Profit after Tax (NOPAT)	146	4,139	1,412	1,084	3,647	8,109	1,803	1,144
NOPAT Margin	3.22%	22.05%	7.03%	5.18%	13.16%	21.41%	6.20%	4.40%
Net Nonoperating Expense Percent (NNEP)	-4.18%	9.93%	2.34%	6.76%	5.34%	-35.41%	-4.63%	-3.82%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	4.79%	3.09%
Cost of Revenue to Revenue	84.74%	71.28%	72.61%	74.94%	66.05%	59.29%	70.84%	71.01%
SG&A Expenses to Revenue	4.71%	14.70%	15.00%	15.84%	13.77%	10.50%	13.85%	15.71%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	10.67%	7.24%	16.93%	20.74%	16.70%	12.18%	19.45%	20.32%
Earnings before Interest and Taxes (EBIT)	-29	3,494	1,308	382	4,168	10,246	1,952	1,136
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-29	5,086	3,107	2,371	6,119	12,258	4,121	3,475
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	1.00	1.06	1.12	1.72	0.00	1.05	0.91
Price to Tangible Book Value (P/TBV)	0.00	2.26	2.87	3.22	4.47	0.00	2.45	2.10
Price to Revenue (P/Rev)	0.00	1.30	1.21	1.20	1.46	0.00	0.91	0.85
Price to Earnings (P/E)	0.00	3.41	19.70	54.55	6.39	0.00	10.04	12.31
Dividend Yield	0.00%	4.18%	4.23%	4.10%	3.10%	2.72%	3.97%	6.03%
Earnings Yield	0.00%	29.36%	5.08%	1.83%	15.66%	0.00%	9.96%	8.12%
Enterprise Value to Invested Capital (EV/IC)	0.00	1.00	1.04	1.08	1.53	0.00	2.82	2.63
Enterprise Value to Revenue (EV/Rev)	0.00	1.68	1.68	1.63	1.77	0.00	1.31	1.31
Enterprise Value to EBITDA (EV/EBITDA)	0.00	6.19	10.84	14.40	8.01	0.00	9.24	9.76
Enterprise Value to EBIT (EV/EBIT)	0.00	9.01	25.74	89.36	11.76	0.00	19.50	29.86
Enterprise Value to NOPAT (EV/NOPAT)	0.00	7.60	23.84	31.50	13.44	0.00	21.11	29.66
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	15.33	9.19	10.27	12.61	0.00	13.30	12.09
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	18.42	16.22	0.00	11.35	19.45
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.53	0.38	0.48	0.50	0.41	0.46	0.49	0.52
Long-Term Debt to Equity	0.45	0.32	0.41	0.49	0.32	0.35	0.40	0.41
Financial Leverage	0.52	0.35	0.33	0.41	0.38	-0.05	-0.44	-0.47
Leverage Ratio	2.05	1.91	1.95	2.08	2.11	2.11	2.10	2.11
Compound Leverage Factor	2.05	1.91	1.95	2.08	2.11	2.11	2.10	2.11
Debt to Total Capital	34.85%	27.77%	32.26%	33.15%	28.89%	31.44%	33.05%	34.04%
Short-Term Debt to Total Capital	5.73%	4.80%	4.38%	0.52%	6.32%	7.12%	6.18%	6.94%
Long-Term Debt to Total Capital	29.12%	22.97%	27.88%	32.64%	22.57%	24.32%	26.87%	27.10%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.12%	0.12%	0.09%
Common Equity to Total Capital	65.15%	72.23%	67.74%	66.73%	70.97%	68.44%	66.83%	65.86%
Debt to EBITDA	-153.14	1.85	3.51	4.69	1.57	0.97	3.02	3.63
Net Debt to EBITDA	-149.14	1.39	3.02	3.84	1.38	0.89	2.79	3.38
Long-Term Debt to EBITDA	-127.97	1.53	3.03	4.61	1.23	0.75	2.45	2.89
Debt to NOPAT	30.36	2.27	7.71	10.25	2.64	1.46	6.90	11.03
Net Debt to NOPAT	29.56	1.71	6.66	8.39	2.31	1.35	6.38	10.28
Long-Term Debt to NOPAT	25.37	1.88	6.67	10.09	2.06	1.13	5.61	8.78
Altman Z-Score	0.00	1.69	1.38	1.35	2.02	0.00	1.60	1.40
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.08%	0.18%	0.19%	0.18%	0.16%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	2.07	1.40	1.17	1.35	1.11	1.14	1.17	1.15
Quick Ratio	0.38	0.68	0.46	0.60	0.47	0.50	0.52	0.52
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-14,735	-407	1,853	3,022	25,179	3,354	1,744
Operating Cash Flow to CapEx	-188.17%	0.00%	193.81%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.27	0.60	0.44	0.44	0.57	0.72	0.54	0.50
Accounts Receivable Turnover	9.30	9.80	5.84	5.83	6.16	6.55	5.01	4.82
Inventory Turnover	1.46	3.54	2.95	3.16	3.25	3.22	2.95	2.95
Fixed Asset Turnover	0.00	0.00	1.03	1.05	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	0.00	2.06	2.02	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	39.25	37.24	62.55	62.57	59.22	55.69	72.81	75.81
Days Inventory Outstanding (DIO)	250.66	103.16	123.80	115.37	112.25	113.43	123.85	123.54
Days Payable Outstanding (DPO)	0.00	0.00	176.97	180.47	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	289.91	140.40	9.39	-2.54	171.47	169.12	196.66	199.35
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	12,628	31,502	32,267	31,498	32,123	15,053	13,502	12,902
Invested Capital Turnover	0.36	0.85	0.64	0.66	0.87	1.61	2.04	1.97
Increase / (Decrease) in Invested Capital	0.00	18,874	1,819	-769	625	-17,070	-1,551	-600
Enterprise Value (EV)	0.00	31,465	33,669	34,135	49,020	0.00	38,059	33,920
Market Capitalization	0.00	24,388	24,271	25,040	40,596	0.00	26,516	22,123
Book Value per Share	$9.88	$39.09	$37.58	$39.04	$41.55	$47.95	$50.68	$49.39
Tangible Book Value per Share	$9.69	$17.26	$13.89	$13.58	$15.97	$20.71	$21.81	$21.34
Total Capital	12,744	33,816	33,759	33,514	33,325	37,721	37,640	37,057
Total Debt	4,441	9,391	10,890	11,111	9,626	11,858	12,439	12,615
Total Long-Term Debt	3,711	7,767	9,412	10,938	7,521	9,174	10,112	10,044
Net Debt	4,325	7,077	9,398	9,095	8,424	10,957	11,498	11,762
Capital Expenditures (CapEx)	651	0.00	1,891	0.00	0.00	0.00	0.00	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2,335	2,637	2,343	1,709	3,009	3,845	3,435	3,465
Debt-free Net Working Capital (DFNWC)	2,451	4,951	3,014	3,163	3,508	4,746	4,376	4,318
Net Working Capital (NWC)	1,721	3,327	1,536	2,990	1,403	2,062	2,049	1,747
Net Nonoperating Expense (NNE)	-181	566	180	625	468	422	521	444
Net Nonoperating Obligations (NNO)	4,325	7,077	9,398	9,095	8,424	-10,810	-11,699	-11,540
Total Depreciation and Amortization (D&A)	0.00	1,592	1,799	1,989	1,951	2,012	2,169	2,339
Debt-free, Cash-free Net Working Capital to Revenue	51.35%	14.05%	11.67%	8.17%	10.86%	10.15%	11.82%	13.34%
Debt-free Net Working Capital to Revenue	53.90%	26.37%	15.01%	15.13%	12.66%	12.53%	15.06%	16.63%
Net Working Capital to Revenue	37.85%	17.72%	7.65%	14.30%	5.06%	5.44%	7.05%	6.73%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$5.72	$3.40	$0.81	$5.53	$14.22	$2.53	$1.36
Adjusted Weighted Average Basic Shares Outstanding	0.00	624.90M	582.27M	569.66M	569.66M	538.48M	496.38M	494.20M
Adjusted Diluted Earnings per Share	$0.00	$5.72	$1.70	$0.81	$5.52	$14.18	$2.53	$1.36
Adjusted Weighted Average Diluted Shares Outstanding	0.00	624.90M	583.10M	569.69M	571.29M	540.01M	496.99M	494.37M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	608.54M	572.94M	569.26M	0.00	0.00	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	146	1,556	1,321	1,208	3,672	7,524	2,311	1,470
Normalized NOPAT Margin	3.22%	8.29%	6.58%	5.78%	13.25%	19.86%	7.95%	5.66%
Pre Tax Income Margin	-0.64%	18.61%	6.51%	1.83%	15.04%	27.05%	6.72%	4.37%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	100.92%	26.64%	82.95%	224.40%	32.87%	0.00%	0.00%	0.00%
Augmented Payout Ratio	100.92%	77.02%	239.61%	259.26%	65.43%	0.00%	0.00%	0.00%

No quarterly metrics and ratios for Nutrien are available.

Frequently Asked Questions About Nutrien's Financials

When does Nutrien's financial year end?

According to the most recent income statement we have on file, Nutrien's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Nutrien's net income changed over the last 7 years?

Nutrien's net income appears to be on an upward trend, with a most recent value of $700 million in 2024, rising from $327 million in 2017. The previous period was $1.28 billion in 2023. Check out Nutrien's forecast to explore projected trends and price targets.

What is Nutrien's operating income?

Nutrien's total operating income in 2024 was $1.86 billion, based on the following breakdown:

Total Gross Profit: $7.53 billion
Total Operating Expenses: $5.28 billion

How has Nutrien revenue changed over the last 7 years?

Over the last 7 years, Nutrien's total revenue changed from $4.55 billion in 2017 to $25.97 billion in 2024, a change of 471.2%.

How much debt does Nutrien have?

Nutrien's total liabilities were at $27.40 billion at the end of 2024, a 0.5% decrease from 2023, and a 215.1% increase since 2017.

How much cash does Nutrien have?

In the past 7 years, Nutrien's cash and equivalents has ranged from $116 million in 2017 to $2.31 billion in 2018, and is currently $853 million as of their latest financial filing in 2024.

How has Nutrien's book value per share changed over the last 7 years?

Over the last 7 years, Nutrien's book value per share changed from 9.88 in 2017 to 49.39 in 2024, a change of 399.7%.

Related Companies

This page (NYSE:NTR) was last updated on 5/6/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nutrien (NTR) Financials

Frequently Asked Questions About Nutrien's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nutrien (NTR) Financials

Annual Income Statements for Nutrien

Quarterly Income Statements for Nutrien

Annual Cash Flow Statements for Nutrien

Quarterly Cash Flow Statements for Nutrien

Annual Balance Sheets for Nutrien

Quarterly Balance Sheets for Nutrien

Annual Metrics and Ratios for Nutrien

Quarterly Metrics and Ratios for Nutrien

Frequently Asked Questions About Nutrien's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools